FeesSafety
Pluang+

Ocean Power and Stratum partner to demo offshore data centers powered by wave, wind, and solar energy.

Market News
26 Oct 2026, 14:30 WIB
GlobeNewsWire
View Source
Bullish
Ocean Power and Stratum partner to demo offshore data centers powered by wave, wind, and solar energy.

Ocean Power Technologies and Stratum Holdings have signed a non-binding letter of intent to collaborate on demonstrating offshore data centers powered by renewable wave, wind, and solar energy. The partnership will combine Ocean Power's patented PowerBuoy® platforms with Stratum's GPU infrastructure to test edge AI workloads without shore power. This initiative aims to validate the technical feasibility of self-powered offshore AI systems, potentially reducing cooling costs by leveraging ocean temperatures. The collaboration will focus on system integration, performance validation, and data collection to explore future commercial applications in maritime and remote computing environments.

Ocean Power Technologies and Stratum Holdings' planned offshore renewable-powered data center collaboration is presented here with Pluang's Technology sector market snapshot as of Oct 26, 2026 18:01 WIB: Out of 150 priced US Technology stocks, 70 rose and 65 fell. Notable movers include Applied Digital Corporation (APLD) at USD 17.70, down 3.01% with a typical hold time of 27 days, Nutanix Inc (NTNX) at USD 72.57, up 2.82% with a typical hold time of 18 days, and Bitdeer Technologies Group (BTDR) at USD 6.78, down 2.59% with a typical hold time of 16 days.

More News

Corxel US to go public via merger with Amanat Acquisition, raising $377M to advance oral obesity drugs.

Corxel US to go public via merger with Amanat Acquisition, raising $377M to advance oral obesity drugs.

Corxel Pharmaceuticals US and Amanat Acquisition Corp have agreed to merge, creating a publicly traded biopharmaceutical company focused on oral obesity treatments. The deal will raise approximately $377 million, including $300 million from private i...

Company Fundamentals
Bullish
1 hour ago
EIK1001 combo shows strong response in advanced lung cancer with good safety, advancing to Phase 2/3 trial.

EIK1001 combo shows strong response in advanced lung cancer with good safety, advancing to Phase 2/3 trial.

Eikon Therapeutics presented updated data on EIK1001, a TLR7/8 dual-agonist, combined with pembrolizumab and chemotherapy for stage 4 non-small cell lung cancer (NSCLC) at the 2026 ESMO Congress. The treatment showed a 72% objective response rate and...

Company Fundamentals
Bullish
1 hour ago
Microsoft, Alphabet, and Amazon, 15% of S&P 500, report earnings within 2 days.

Microsoft, Alphabet, and Amazon, 15% of S&P 500, report earnings within 2 days.

Microsoft, Alphabet, and Amazon together represent about 15% of the S&P 500 index. All three tech giants are scheduled to report their quarterly earnings within a two-day span. These earnings reports are highly anticipated as they provide insight int...

Company Fundamentals
Neutral
2 hours ago
Conow launches Atlas 6000 AC, a 6kWh AI-powered home battery for solar upgrades in Germany.

Conow launches Atlas 6000 AC, a 6kWh AI-powered home battery for solar upgrades in Germany.

Conow, in partnership with Tuya Smart, has introduced the Atlas 6000 AC in Germany, a 6 kWh AC-coupled plug-and-play home battery designed to upgrade existing rooftop solar systems. This battery features AI-driven energy management that optimizes hou...

Others
Bullish
2 hours ago
Phase-3 study shows Trastuzumab Pamirtecan improves progression-free survival in HR+/HER2-low metastatic breast cancer.

Phase-3 study shows Trastuzumab Pamirtecan improves progression-free survival in HR+/HER2-low metastatic breast cancer.

BioNTech and DualityBio announced that their Phase-3 clinical trial DYNASTY-Breast02 met its primary endpoint, demonstrating a statistically significant but moderate improvement in progression-free survival for Trastuzumab Pamirtecan compared to chem...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App